[Cancer immunotherapy: new approaches]

Bull Cancer. 2000 Jan;87(1):97-106.
[Article in French]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cancer Vaccines / therapeutic use
  • Humans
  • Immunization, Passive / methods
  • Immunotherapy / methods*
  • Interferons / therapeutic use*
  • Interleukin-2 / therapeutic use*
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck) / metabolism
  • Neoplasm Proteins / metabolism
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • T-Lymphocytes, Cytotoxic / transplantation*

Substances

  • Cancer Vaccines
  • Interleukin-2
  • Neoplasm Proteins
  • Interferons
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck)